Moderna, Inc (MRNA) insider trading
Every open-market stock purchase and sale by Moderna, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Stephane Bancel (CEO) and 3 others sold $49.2M in the last 90 days.
- Last insider buy: Stephane Bancel (CEO), $3.2M, 19 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $64.6M (14 sales). Last close $154.04 on Sep 18, 2026.
Recent MRNA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 15, 2026 | Stephen Hoge (President) | Sold | $5.9M |
| Sep 15, 2026 | Stephen Hoge (President) | Bought (not open market) | — |
| Sep 14, 2026 | Stephen Hoge (President) | Sold | $5.8M |
| Sep 14, 2026 | Stephen Hoge (President) | Bought (not open market) | — |
| Sep 10, 2026 | James M Mock (CFO) | Sold | $2.7M |
| Sep 10, 2026 | James M Mock (CFO) | Sold | $2M |
| Sep 10, 2026 | James M Mock (CFO) | Bought (not open market) | — |
| Sep 4, 2026 | James M Mock (CFO) | Sold (not open market) | $849K |
| Sep 4, 2026 | Shannon Thyme Klinger (C-suite exec) | Sold (not open market) | $849K |
| Sep 4, 2026 | Shannon Thyme Klinger (C-suite exec) | Bought (not open market) | — |
| Sep 4, 2026 | James M Mock (CFO) | Bought (not open market) | — |
| Sep 1, 2026 | Stephen Hoge (President) | Sold (not open market) | $630K |
| Sep 1, 2026 | Shannon Thyme Klinger (C-suite exec) | Sold | $486K |
| Sep 1, 2026 | James M Mock (CFO) | Sold (not open market) | $168K |
| Sep 1, 2026 | Shannon Thyme Klinger (C-suite exec) | Sold (not open market) | $147K |
| Sep 1, 2026 | Shannon Thyme Klinger (C-suite exec) | Bought (not open market) | — |
| Sep 1, 2026 | James M Mock (CFO) | Bought (not open market) | — |
| Sep 1, 2026 | Stephen Hoge (President) | Bought (not open market) | — |
| Sep 1, 2026 | Shannon Thyme Klinger (C-suite exec) | Bought (not open market) | — |
| Aug 28, 2026 | Stephen Hoge (President) | Sold (not open market) | $42.3K |
| Aug 28, 2026 | James M Mock (CFO) | Sold (not open market) | $22.8K |
| Aug 28, 2026 | Shannon Thyme Klinger (C-suite exec) | Sold (not open market) | $22.8K |
| Aug 28, 2026 | Shannon Thyme Klinger (C-suite exec) | Bought (not open market) | — |
| Aug 28, 2026 | James M Mock (CFO) | Bought (not open market) | — |
| Aug 28, 2026 | Stephen Hoge (President) | Bought (not open market) | — |
Who's trading MRNA
- Stephen Hoge, President: sold $28.4M (6 sales), last Sep 15, 2026
- James M Mock, CFO: sold $4.7M (2 sales), last Sep 10, 2026
- Shannon Thyme Klinger, C-suite exec: sold $1.4M (3 sales), last Sep 4, 2026
- Stephane Bancel, CEO: sold $28.7M (4 sales), last Aug 6, 2026
- Michael R. McDonnell, Director: other filings, last Jul 8, 2026
- Soria Ester Banque, C-suite exec: other filings, last Jul 5, 2026
- Noubar Afeyan, Insider: sold $1.1M (2 sales), last May 21, 2026
- Abbas Hussain, Director: sold $279K (2 sales), last May 6, 2026
- Sandra Horning, Director: other filings, last May 6, 2026
- Elizabeth G Nabel, Director: other filings, last May 6, 2026
- Francois Nader, Director: other filings, last May 6, 2026
- David M. Rubenstein, Director: other filings, last May 6, 2026
- Elizabeth E Tallett, Director: other filings, last May 6, 2026
Get free alerts when an insider at Moderna, Inc files a new trade →